BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 28574664)

  • 1. Chemokine (CC motif) ligand 18 upregulates Slug expression to promote stem-cell like features by activating the mammalian target of rapamycin pathway in oral squamous cell carcinoma.
    Wang H; Liang X; Li M; Tao X; Tai S; Fan Z; Wang Z; Cheng B; Xia J
    Cancer Sci; 2017 Aug; 108(8):1584-1593. PubMed ID: 28574664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCL18-NIR1 promotes oral cancer cell growth and metastasis by activating the JAK2/STAT3 signaling pathway.
    Jiang X; Huang Z; Sun X; Zheng X; Liu J; Shen J; Jia B; Luo H; Mai Z; Chen G; Zhao J
    BMC Cancer; 2020 Jul; 20(1):632. PubMed ID: 32641093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated autocrine chemokine ligand 18 expression promotes oral cancer cell growth and invasion via Akt activation.
    Jiang X; Wang J; Chen X; Hong Y; Wu T; Chen X; Xia J; Cheng B
    Oncotarget; 2016 Mar; 7(13):16262-72. PubMed ID: 26919103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis.
    Yu CC; Chen PN; Peng CY; Yu CH; Chou MY
    Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MUC1 gene silencing inhibits proliferation, invasion, and migration while promoting apoptosis of oral squamous cell carcinoma cells.
    Zhang AM; Chi XH; Bo ZQ; Huang XF; Zhang J
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31439759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disclosure of a stem cell phenotype in an oral squamous cell carcinoma cell line induced by BMP-4 via an epithelial-mesenchymal transition.
    Qiao B; Johnson NW; Chen X; Li R; Tao Q; Gao J
    Oncol Rep; 2011 Aug; 26(2):455-61. PubMed ID: 21567100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methanol extract of Sedum oryzifolium and its constituent, trehalose, impede the invasiveness of oral squamous cell carcinoma cell lines via downregulation of Slug.
    Shin JA; Won DH; Swarup N; Ahn MH; Yang SO; Chawla K; Kim J; Choi SJ; Ahn CH; Oh KY; Yoon HJ; Lee JI; Hong SD; Hong KO; Cho SD
    Phytomedicine; 2021 Oct; 91():153670. PubMed ID: 34391081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD47-SIRPα Signaling Induces Epithelial-Mesenchymal Transition and Cancer Stemness and Links to a Poor Prognosis in Patients with Oral Squamous Cell Carcinoma.
    Pai S; Bamodu OA; Lin YK; Lin CS; Chu PY; Chien MH; Wang LS; Hsiao M; Yeh CT; Tsai JT
    Cells; 2019 Dec; 8(12):. PubMed ID: 31861233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCL18 from tumor-cells promotes epithelial ovarian cancer metastasis via mTOR signaling pathway.
    Wang Q; Tang Y; Yu H; Yin Q; Li M; Shi L; Zhang W; Li D; Li L
    Mol Carcinog; 2016 Nov; 55(11):1688-1699. PubMed ID: 26457987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary tumor-transforming gene 1 (PTTG1) is overexpressed in oral squamous cell carcinoma (OSCC) and promotes migration, invasion and epithelial-mesenchymal transition (EMT) in SCC15 cells.
    Zhang E; Liu S; Xu Z; Huang S; Tan X; Sun C; Lu L
    Tumour Biol; 2014 Sep; 35(9):8801-11. PubMed ID: 24879625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nir1 promotes invasion of breast cancer cells by binding to chemokine (C-C motif) ligand 18 through the PI3K/Akt/GSK3β/Snail signalling pathway.
    Zhang B; Yin C; Li H; Shi L; Liu N; Sun Y; Lu S; Liu Y; Sun L; Li X; Chen W; Qi Y
    Eur J Cancer; 2013 Dec; 49(18):3900-13. PubMed ID: 24001613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCL18 promotes the metastasis of squamous cell carcinoma of the head and neck through MTDH-NF-κB signalling pathway.
    Qin Y; Wang J; Zhu G; Li G; Tan H; Chen C; Pi L; She L; Chen X; Wei M; Li Z; Liu Z; Huang D; Liu Y; Zhang X
    J Cell Mol Med; 2019 Apr; 23(4):2689-2701. PubMed ID: 30768878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCL18-induced LINC00319 promotes proliferation and metastasis in oral squamous cell carcinoma via the miR-199a-5p/FZD4 axis.
    Jiang X; Liu J; Li S; Jia B; Huang Z; Shen J; Luo H; Zhao J
    Cell Death Dis; 2020 Sep; 11(9):777. PubMed ID: 32948745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour cell-derived WNT5B modulates in vitro lymphangiogenesis via induction of partial endothelial-mesenchymal transition of lymphatic endothelial cells.
    Wang SH; Chang JS; Hsiao JR; Yen YC; Jiang SS; Liu SH; Chen YL; Shen YY; Chang JY; Chen YW
    Oncogene; 2017 Mar; 36(11):1503-1515. PubMed ID: 27593938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The serum biomarker chemerin promotes tumorigenesis and metastasis in oral squamous cell carcinoma.
    Lu Z; Liang J; He Q; Wan Q; Hou J; Lian K; Wang A
    Clin Sci (Lond); 2019 Mar; 133(5):681-695. PubMed ID: 30804218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor tyrosine kinase, RON, promotes tumor progression by regulating EMT and the MAPK signaling pathway in human oral squamous cell carcinoma.
    Kim SA; Lee KH; Lee DH; Lee JK; Lim SC; Joo YE; Chung IJ; Noh MG; Yoon TM
    Int J Oncol; 2019 Aug; 55(2):513-526. PubMed ID: 31268163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Antihelminthic Niclosamide Inhibits Cancer Stemness, Extracellular Matrix Remodeling, and Metastasis through Dysregulation of the Nuclear β-catenin/c-Myc axis in OSCC.
    Wang LH; Xu M; Fu LQ; Chen XY; Yang F
    Sci Rep; 2018 Aug; 8(1):12776. PubMed ID: 30143678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropilin-1 promotes epithelial-to-mesenchymal transition by stimulating nuclear factor-kappa B and is associated with poor prognosis in human oral squamous cell carcinoma.
    Chu W; Song X; Yang X; Ma L; Zhu J; He M; Wang Z; Wu Y
    PLoS One; 2014; 9(7):e101931. PubMed ID: 24999732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADAR1 promotes the epithelial-to-mesenchymal transition and stem-like cell phenotype of oral cancer by facilitating oncogenic microRNA maturation.
    Liu X; Fu Y; Huang J; Wu M; Zhang Z; Xu R; Zhang P; Zhao S; Liu L; Jiang H
    J Exp Clin Cancer Res; 2019 Jul; 38(1):315. PubMed ID: 31315644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
    Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
    Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.